HomeCompliance Update → HHS Proposes Changes to Drug Rebate Safe Harbors

HHS Proposes Changes to Drug Rebate Safe Harbors Print E-mail
Written by Vitale Health Law   
Tuesday, 12 February 2019 00:00
The U.S. Department of Health & Human Services (HHS) has issued a proposed rule that would amend the safe harbor regulation for certain drug rebates that manufacturers pay to pharmacy benefit managers (PBMs) Medicare Part D, and Medicaid managed care organizations (MCOs). Published in the Federal Register on February 6, the proposal is designed to address criticism that these rebates have contributed to the skyrocketing costs of prescription drugs.

"The prominence of rebate arrangements in the prescription drug supply chain has been cited as a potential barrier to lowering drug costs," HHS notes in its proposed rule.
Read More

Last Updated on Wednesday, 13 February 2019 08:50

Website design, development, and hosting provided by